dostarlimab
gsk
['dostarlimab']
clinical data presented at #asco shows all 12 cancer patients treated with anti-pd-1 antibody, dostarlimab, had a complete response, with no evidence of tumor. #immunotherapy #cancerresearch 
OrganaBio is on a mission to transform a world of research into a world of cell therapies.